Disruption of Circulating CD4+ T-Lymphocyte Subpopulations in Psoriasis Patients is Ameliorated by Narrow-Band UVB Therapy

[1]  P. Miossec,et al.  Th17 and regulatory T cell balance in autoimmune and inflammatory diseases. , 2014, Autoimmunity reviews.

[2]  G. Wang,et al.  Keratin 17: A Critical Player in the Pathogenesis of Psoriasis , 2014, Medicinal research reviews.

[3]  S. Youssef,et al.  Effect of Narrow Band Ultraviolet B Therapy versus Methotrexate on Serum Levels of Interleukin-17 and Interleukin-23 in Egyptian Patients with Severe Psoriasis , 2013, Dermatology research and practice.

[4]  Björn Rúnar Lúðvíksson,et al.  The Role of Th17/Tc17 Peripheral Blood T cells in Psoriasis and Their Positive Therapeutic Response , 2013, Scandinavian journal of immunology.

[5]  C. Enerbäck,et al.  Systemically elevated Th1-, Th2- and Th17-associated chemokines in psoriasis vulgaris before and after ultraviolet B treatment. , 2013, Acta dermato-venereologica.

[6]  D. Foti,et al.  Psoriasis, a new challenge for laboratory medicine , 2013, Clinical chemistry and laboratory medicine.

[7]  P. An,et al.  Narrowband Ultraviolet B Interferes with Gene Expression in the Peripheral Blood T Cells of Patients with Psoriasis , 2013, Dermatology.

[8]  S. Sakaguchi,et al.  Development and maintenance of regulatory T cells. , 2013, Immunity.

[9]  K. Scharffetter-Kochanek,et al.  Reduced CD18 Levels Drive Regulatory T Cell Conversion into Th17 Cells in the CD18hypo PL/J Mouse Model of Psoriasis , 2013, The Journal of Immunology.

[10]  Luis Mendoza.  A Virtual Culture of CD4+ T Lymphocytes , 2013, Bulletin of Mathematical Biology.

[11]  S. Yamazaki,et al.  Photo(chemo)therapy Reduces Circulating Th17 Cells and Restores Circulating Regulatory T Cells in Psoriasis , 2013, PloS one.

[12]  Jun Yan,et al.  New insights of T cells in the pathogenesis of psoriasis , 2012, Cellular and Molecular Immunology.

[13]  Gang Wang,et al.  IL-17A upregulates keratin 17 expression in keratinocytes through STAT1- and STAT3-dependent mechanisms. , 2011, The Journal of investigative dermatology.

[14]  P. van Erp,et al.  Foxp3+ regulatory T cells of psoriasis patients easily differentiate into IL-17A-producing cells and are found in lesional skin. , 2011, The Journal of investigative dermatology.

[15]  W. V. van IJcken,et al.  Effective treatment of psoriasis with narrow-band UVB phototherapy is linked to suppression of the IFN and Th17 pathways. , 2011, The Journal of investigative dermatology.

[16]  S. Chang,et al.  Role of CD4CD25FOXP3 Regulatory T Cells in Psoriasis. , 2010, Annals of dermatology.

[17]  M. Suárez-Fariñas,et al.  Effective narrow-band UVB radiation therapy suppresses the IL-23/IL-17 axis in normalized psoriasis plaques. , 2010, The Journal of investigative dermatology.

[18]  A. Blauvelt,et al.  Circulating Th17, Th22, and Th1 cells are increased in psoriasis. , 2010, The Journal of investigative dermatology.

[19]  Juan Cheng,et al.  Increased Th17 cells are accompanied by FoxP3(+) Treg cell accumulation and correlated with psoriasis disease severity. , 2010, Clinical immunology.

[20]  R. B. Kjellerup,et al.  Characterization of the interleukin‐17 isoforms and receptors in lesional psoriatic skin , 2009, The British journal of dermatology.

[21]  L. Fouser,et al.  Th17 cytokines and their emerging roles in inflammation and autoimmunity , 2008, Immunological reviews.

[22]  Lisa C. Zaba,et al.  Psoriasis vulgaris lesions contain discrete populations of Th1 and Th17 T cells. , 2008, The Journal of investigative dermatology.

[23]  A. de Silvestri,et al.  The Duration of Clinical Remission of Photochemotherapy and Narrow-Band UV-B Phototherapy in the Treatment of Psoriasis: A Retrospective Study , 2008, International journal of immunopathology and pharmacology.

[24]  Shimon Sakaguchi,et al.  Natural regulatory T cells: mechanisms of suppression. , 2007, Trends in molecular medicine.

[25]  Kathleen M. Smith,et al.  IL-23 stimulates epidermal hyperplasia via TNF and IL-20R2–dependent mechanisms with implications for psoriasis pathogenesis , 2006, The Journal of experimental medicine.

[26]  T. Horio,et al.  Ultraviolet B radiation suppresses Langerhans cell migration in the dermis by down‐regulation of α4 integrin , 2006, Photodermatology, photoimmunology & photomedicine.

[27]  R. D. Hatton,et al.  Interleukin 17–producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages , 2005, Nature Immunology.

[28]  Ying Wang,et al.  A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17 , 2005, Nature Immunology.

[29]  J. Gudjonsson,et al.  Narrowband–UVB irradiation decreases the production of pro-inflammatory cytokines by stimulated T cells , 2005, Archives of Dermatological Research.

[30]  J. Bos,et al.  Clinical improvement in chronic plaque‐type psoriasis lesions after narrow‐band UVB therapy is accompanied by a decrease in the expression of IFN‐γ inducers – IL‐12, IL‐18 and IL‐23 , 2004, Experimental dermatology.

[31]  P. Kidd.  Th1/Th2 balance: the hypothesis, its limitations, and implications for health and disease. , 2003, Alternative medicine review : a journal of clinical therapeutic.

[32]  J. Bos,et al.  Ultraviolet‐B irradiation decreases IFN‐γ and increases IL‐4 expression in psoriatic lesional skin in situ and in cultured dermal T cells derived from these lesions , 2003, Experimental dermatology.

[33]  J. Krueger,et al.  Narrowband (312-nm) UV-B suppresses interferon gamma and interleukin (IL) 12 and increases IL-4 transcripts: differential regulation of cytokines at the single-cell level. , 2003, Archives of dermatology.

[34]  S. Romagnani,et al.  T-cell subsets (Th1 versus Th2). , 2000, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[35]  L. Austin,et al.  312-nanometer Ultraviolet B Light (Narrow-Band UVB) Induces Apoptosis of  T Cells within Psoriatic Lesions , 1999, The Journal of experimental medicine.

[36]  J. Krejsek,et al.  The number of immunoregulatory T cells is increased in patients with psoriasis after Goeckerman therapy. , 2012, Acta medica.